Header Image for Inside Symbicort Vs Advair

Inside Symbicort Vs Advair

Introduction

Comparison Details

Considerations for Use

Introduction: Symbicort vs. Advair, Drug Features Compared

Managing asthma or chronic obstructive pulmonary disease (COPD) involves selecting an appropriate inhaler for symptom control and flare-up prevention. Two widely prescribed options are Symbicort and Advair. These medications, while serving the same purpose, operate through somewhat different mechanisms.

Symbicort combines budesonide, an anti-inflammatory corticosteroid that reduces swelling in the airways, with formoterol, a long-acting beta agonist (LABA) that aids in opening up airways by relaxing muscles around them. This dual-action approach is designed to offer better control over asthma or COPD symptoms compared to monotherapy.

Conversely, Advair employs a combination of fluticasone, another corticosteroid for reducing inflammation, and salmeterol, a LABA for easing muscle tension around the airways. Through its unique composition, Advair targets both inflammation and bronchoconstriction (tightening of muscles around the airways), utilizing different active ingredients.

The distinction between these medications lies in their composition, dosing requirements, potential side effects, and interaction profiles with other drugs.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

Cost, Availability, and Side Effects of Symbicort and Advair

Symbicort and Advair are medications for asthma and chronic obstructive pulmonary disease (COPD), known for reducing inflammation in the lungs. The cost of Symbicort and Advair can vary based on location, insurance coverage, and pharmacy. Without insurance, these medications can be expensive. Manufacturer assistance programs may offer cost reduction. It is beneficial to explore different pharmacies for pricing.

Both Symbicort and Advair are available in pharmacies across the United States with a prescription. Generic versions of both medications are also available, which may be a lower-cost alternative.

Regarding side effects, both medications can cause:

  • throat irritation,
  • hoarseness or voice changes,
  • oral thrush (a fungal infection in the mouth), and
  • headaches.

More serious side effects, though rare, include:

  • increased blood pressure,
  • a fast heartbeat, and
  • changes in vision.

It is noted that rinsing the mouth with water after using these inhalers can decrease the risk of oral thrush.

The understanding of costs, availability, and potential side effects is important for those considering treatment with Symbicort or Advair.

Drug Interactions, Warnings, and Choosing Between Symbicort and Advair

Symbicort and Advair are both used to treat asthma and chronic obstructive pulmonary disease (COPD), containing steroids and bronchodilators. They can interact with similar medications, such as beta-blockers, diuretics, MAO inhibitors, antidepressants, and other bronchodilators, increasing the risk of side effects.

Warnings for both medications highlight the importance of not using them as a rescue inhaler in case of an asthma attack; they are maintenance therapies only. Side effects may include oral thrush, sore throat, hoarseness, coughing, headache, or stomach discomfort. Long-term use is associated with potential increased risks for osteoporosis and glaucoma, especially in patients with predisposing factors for these conditions.

The decision between Symbicort and Advair involves considering the active ingredients; Symbicort contains budesonide/formoterol, while Advair consists of fluticasone/salmeterol. Budesonide has slightly fewer systemic side effects due to its lower bioavailability compared to fluticasone. The choice may depend on individual response, as some patients may find one medication more effective or tolerable than the other.

  • Healthcare providers also assess patient’s ease of use preferences; Advair Diskus is a dry powder inhaler, whereas Symbicort uses a metered dose inhaler format, which might be considered easier for some users to operate.
  • Cost is another factor, as insurance coverage varies greatly between individuals. It's essential to consider any personal health history issues, like heart conditions or high blood pressure, that could influence the choice based on the specific safety profiles.

Knowledge on drug interactions and warnings can contribute to the selection process between Symbicort and Advair in treatment plans.

Refrences

  • Halpin, D. M. (2008, January). Symbicort: a pharmacoeconomic review. Journal of Medical Economics. Informa UK Limited.http://doi.org/10.3111/13696990802210984
  • Berger, W. E., & Noonan, M. J. (2010, May). Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β<sub>2</sub>-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler. Journal of Asthma. Informa UK Limited.http://doi.org/10.3109/02770901003725684
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top